Ghent University Academic Bibliography

Incorrect interpretation of the role of COVID-19 vaccination boosters in saving lives

Tijl De Bie (UGent)

(2025) LANCET RESPIRATORY MEDICINE. 13(1). p.e4-e4

Augmenting clinical trials in asthma through digital technology, decentralised designs, and person-centric endpoints : opportunities and challenges

Job F M van Boven, Richard W Costello, Kit C B Roes, Guy Brusselle (UGent) , Kjeld Hansen, Jerry A Krishnan, Christopher E Brightling, Nicolas Roche, Salman Siddiqui, Bruce J Kirenga, et al.

(2025) LANCET RESPIRATORY MEDICINE. 13(2). p.177-188

Add to list

Journal Article
A1
open access

Predictors and associations of the persistent airflow limitation phenotype in asthma : a post-hoc analysis of the ATLANTIS study

Tessa M. Kole, Elise Vanden Berghe, Monica Kraft, Judith M. Vonk, Martijn C. Nawijn, Salman Siddiqui, Kai Sun, Leonardo M. Fabbri, Klaus F. Rabe, Kian Fan Chung, et al.

(2023) LANCET RESPIRATORY MEDICINE. 11(1). p.55-64

Add to list

Journal Article
A1
open access

COPD and multimorbidity : recognising and addressing a syndemic occurrence

Leonardo M. Fabbri, Bartolome R. Celli, Alvar Agusti, Gerard J. Criner, Mark T. Dransfield, Miguel Divo, Jamuna K. Krishnan, Lies Lahousse (UGent) , Maria Montes de Oca, Sundeep S. Salvi, et al.

(2023) LANCET RESPIRATORY MEDICINE. 11(11). p.1020-1034

Add to list

Journal Article
A1
open access

Safety and efficacy of vanzacaftor–tezacaftor–deutivacaftor in adults with cystic fibrosis : randomised, double-blind, controlled, phase 2 trials

Ahmet Z Uluer, Gordon MacGregor, Pilar Azevedo, Veronica Indihar, Claire Keating, Marcus A Mall, Edward F McKone, Bonnie W Ramsey, Steven M Rowe, Ronald C Rubenstein, et al.

(2023) LANCET RESPIRATORY MEDICINE. 11(6). p.550-562

Add to list

Journal Article
A1
open access

Discussions on VT4COVID

Jan De Mey and Pieter Depuydt (UGent)

(2023) LANCET RESPIRATORY MEDICINE. 11(11). p.E90-E90

Add to list

Prospective evaluation of the efficacy, safety, and optimal biomarker enrichment strategy for nangibotide, aTREM-1 inhibitor, in patients with septic shock (ASTONISH) : a double-blind, randomised, controlled, phase 2b trial

Bruno Francois, Simon Lambden, Tom Fivez, Sebastien Gibot, Marc Derive, Jean-Marie Grouin, Margarita Salcedo-Magguilli, Jeremie Lemarie, Nicolas De Schryver, Ville Jalkanen, et al.

(2023) LANCET RESPIRATORY MEDICINE. 11(10). p.894-904

Add to list

Miscellaneous

The low flyers : persistent airflow limitation in young adults

Francesca Polverino, George R. Washko, Ronina A. Covar, Eric B. Hysinger, Tillie L. Hackett, Surya P. Bhatt, Guy Brusselle (UGent) and Shyamali C. Dharmage

(2022) LANCET RESPIRATORY MEDICINE. 10(9). p.819-822

Add to list

Changes in lung function in European adults born between 1884 and 1996 and implications for the diagnosis of lung disease : a cross-sectional analysis of ten population-based studies

James P Allinson, Shoaib Afzal, Yunus Çolak, Debbie Jarvis, Helena Backman, Maarten van den Berge, H Marike Boezen, Marie-Kathrin Breyer, Robab Breyer-Kohansal, Guy Brusselle (UGent) , et al.

(2022) LANCET RESPIRATORY MEDICINE. 10(1). p.83-94

Add to list

Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE) : an open-label extension study

Michael E Wechsler, Linda B Ford, Jorge F Maspero, Ian D Pavord, Alberto Papi, Arnaud Bourdin, Henrik Watz, Mario Castro, Natalia M Nenasheva, Yuji Tohda, et al.

(2022) LANCET RESPIRATORY MEDICINE. 10(1). p.11-25

Academic Bibliography

Incorrect interpretation of the role of COVID-19 vaccination boosters in saving lives

Augmenting clinical trials in asthma through digital technology, decentralised designs, and person-centric endpoints : opportunities and challenges

Predictors and associations of the persistent airflow limitation phenotype in asthma : a post-hoc analysis of the ATLANTIS study

COPD and multimorbidity : recognising and addressing a syndemic occurrence

Safety and efficacy of vanzacaftor–tezacaftor–deutivacaftor in adults with cystic fibrosis : randomised, double-blind, controlled, phase 2 trials

Discussions on VT4COVID

Prospective evaluation of the efficacy, safety, and optimal biomarker enrichment strategy for nangibotide, aTREM-1 inhibitor, in patients with septic shock (ASTONISH) : a double-blind, randomised, controlled, phase 2b trial

The low flyers : persistent airflow limitation in young adults

Changes in lung function in European adults born between 1884 and 1996 and implications for the diagnosis of lung disease : a cross-sectional analysis of ten population-based studies

Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE) : an open-label extension study

Contents

Support

Contact